{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:44:01Z","timestamp":1793036641115,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61434-5","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:10:59Z","timestamp":1752610259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2715-653X","authenticated-orcid":false,"given":"Qikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-3661","authenticated-orcid":false,"given":"Zhenhan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3723-3775","authenticated-orcid":false,"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-9324","authenticated-orcid":false,"given":"C.","family":"Jeffrey Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-9360","authenticated-orcid":false,"given":"Yuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-3938","authenticated-orcid":false,"given":"Huan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"61434_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"J Fang","year":"2011","unstructured":"Fang, J., Nakamura, H. & Maeda, H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63, 136\u2013151 (2011).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"61434_CR2","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","volume":"27","author":"Y Nakamura","year":"2016","unstructured":"Nakamura, Y., Mochida, A., Choyke, P. L. & Kobayashi, H. Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?. Bioconjug. Chem. 27, 2225\u20132238 (2016).","journal-title":"Bioconjug. Chem."},{"key":"61434_CR3","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1172\/JCI92284","volume":"127","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer. J. Clin. Invest. 127, 2007\u20132018 (2017).","journal-title":"J. Clin. Invest."},{"key":"61434_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566\u2013575 (2020).","journal-title":"Nat. Mater."},{"key":"61434_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.73","volume":"1","author":"SE McNeil","year":"2016","unstructured":"McNeil, S. E. Evaluation of nanomedicines: stick to the basics. Nat. Rev. Mater. 1, 16073 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"61434_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","volume":"14","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat. Nanotechnol. 14, 799\u2013809 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"61434_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","volume":"345","author":"M Ikeda-Imafuku","year":"2022","unstructured":"Ikeda-Imafuku, M. et al. Strategies to improve the EPR effect: a mechanistic perspective and clinical translation. J. Control. Release 345, 512\u2013536 (2022).","journal-title":"J. Control. Release"},{"key":"61434_CR8","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.7150\/thno.38587","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu, X., Jiang, J. & Meng, H. Transcytosis - an effective targeting strategy that is complementary to \u201cEPR effect\u201d for pancreatic cancer nano drug delivery. Theranostics 9, 8018\u20138025 (2019).","journal-title":"Theranostics"},{"key":"61434_CR9","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1021\/acsnano.5b00510","volume":"9","author":"H Meng","year":"2015","unstructured":"Meng, H. et al. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 9, 3540\u20133557 (2015).","journal-title":"ACS Nano"},{"key":"61434_CR10","doi-asserted-by":"publisher","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","volume":"11","author":"A Nel","year":"2017","unstructured":"Nel, A., Ruoslahti, E. & Meng, H. New insights into \u201cpermeability\u201d as in the enhanced permeability and retention effect of cancer nanotherapeutics. ACS Nano 11, 9567\u20139569 (2017).","journal-title":"ACS Nano"},{"key":"61434_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","volume":"22","author":"DE Tylawsky","year":"2023","unstructured":"Tylawsky, D. E. et al. P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis. Nat. Mater. 22, 391\u2013399 (2023).","journal-title":"Nat. Mater."},{"key":"61434_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","volume":"2","author":"A Dasgupta","year":"2024","unstructured":"Dasgupta, A., Sofias, A. M., Kiessling, F. & Lammers, T. Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact. Nat. Rev. Bioeng. 2, 714\u2013716 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"61434_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17996-7","volume":"11","author":"Y Ji","year":"2020","unstructured":"Ji, Y. et al. Use of ratiometrically designed nanocarrier targeting CDK4\/6 and autophagy pathways for effective pancreatic cancer treatment. Nat. Commun. 11, 4249 (2020).","journal-title":"Nat. Commun."},{"key":"61434_CR14","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1016\/j.scib.2024.10.003","volume":"69","author":"M Qin","year":"2024","unstructured":"Qin, M., Feng, Z. & Meng, H. Enhanced transcytosis and retention (ETR) effect. Sci. Bull. 69, 3640\u20133643 (2024).","journal-title":"Sci. Bull."},{"key":"61434_CR15","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","volume":"15","author":"BR Kingston","year":"2021","unstructured":"Kingston, B. R. et al. Specific endothelial cells govern nanoparticle entry into solid tumors. ACS Nano 15, 14080\u201314094 (2021).","journal-title":"ACS Nano"},{"key":"61434_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41565-023-01522-z","volume":"19","author":"D Iannotta","year":"2024","unstructured":"Iannotta, D., A, A., Kijas, A. W., Rowan, A. E. & Wolfram, J. Entry and exit of extracellular vesicles to and from the blood circulation. Nat. Nanotechnol. 19, 13\u201320 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"61434_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41565-023-01531-y","volume":"19","author":"E Nance","year":"2024","unstructured":"Nance, E. Intracerebral fate of engineered nanoparticles. Nat. Nanotechnol. 19, 273\u2013274 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"61434_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1172\/JCI93955","volume":"127","author":"E Ruoslahti","year":"2017","unstructured":"Ruoslahti, E. Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier. J. Clin. Invest. 127, 1622\u20131624 (2017).","journal-title":"J. Clin. Invest."},{"key":"61434_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang, A. C. et al. Physiological blood-brain transport is impaired with age by a shift in transcytosis. Nature 583, 425\u2013430 (2020).","journal-title":"Nature"},{"key":"61434_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120888","volume":"274","author":"W Xiao","year":"2021","unstructured":"Xiao, W. et al. The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood-brain barrier and attenuates their targeting ability to brain tumor. Biomaterials 274, 120888 (2021).","journal-title":"Biomaterials"},{"key":"61434_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24323-1","volume":"12","author":"K Kucharz","year":"2021","unstructured":"Kucharz, K. et al. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles. Nat. Commun. 12, 4121 (2021).","journal-title":"Nat. Commun."},{"key":"61434_CR22","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1021\/acsnano.8b07231","volume":"13","author":"D Yang","year":"2019","unstructured":"Yang, D. et al. Transferrin functionization elevates transcytosis of nanogranules across epithelium by triggering polarity-associated transport flow and positive cellular feedback loop. ACS Nano 13, 5058\u20135076 (2019).","journal-title":"ACS Nano"},{"key":"61434_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114115","volume":"182","author":"S Quader","year":"2022","unstructured":"Quader, S., Kataoka, K. & Cabral, H. Nanomedicine for brain cancer. Adv. Drug Deliv. Rev. 182, 114115 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"61434_CR24","doi-asserted-by":"publisher","first-page":"314ra183","DOI":"10.1126\/scitranslmed.aac6522","volume":"7","author":"MA Miller","year":"2015","unstructured":"Miller, M. A. et al. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci. Transl. Med. 7, 314ra183 (2015).","journal-title":"Sci. Transl. Med."},{"key":"61434_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103745","volume":"9","author":"I Biancacci","year":"2022","unstructured":"Biancacci, I. et al. Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles. Adv. Sci. 9, e2103745 (2022).","journal-title":"Adv. Sci."},{"key":"61434_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/ar3000986","volume":"46","author":"D Tarn","year":"2013","unstructured":"Tarn, D. et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc. Chem. Res. 46, 792\u2013801 (2013).","journal-title":"Acc. Chem. Res."},{"key":"61434_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nmat2992","volume":"10","author":"CE Ashley","year":"2011","unstructured":"Ashley, C. E. et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 10, 389\u2013397 (2011).","journal-title":"Nat. Mater."},{"key":"61434_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/cns.12673","volume":"23","author":"W Fang","year":"2017","unstructured":"Fang, W. et al. Complex roles of annexin A2 in host blood-brain barrier invasion by cryptococcus neoformans. CNS Neurosci. Ther. 23, 291\u2013300 (2017).","journal-title":"CNS Neurosci. Ther."},{"key":"61434_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fcimb.2017.00296","volume":"7","author":"S Na Pombejra","year":"2017","unstructured":"Na Pombejra, S., Salemi, M., Phinney, B. S. & Gelli, A. The metalloprotease, Mpr1, engages annexinA2 to promote the transcytosis of fungal cells across the blood-brain barrier. Front. Cell. Infect. Microbiol. 7, 296 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"61434_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324\u2013338 (2015).","journal-title":"Cell"},{"key":"61434_CR31","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s11426-021-1126-x","volume":"64","author":"Z Feng","year":"2021","unstructured":"Feng, Z. et al. Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology. Sci. China Chem. 64, 1946\u20131957 (2021).","journal-title":"Sci. China Chem."},{"key":"61434_CR32","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1021\/acsnano.5b07781","volume":"10","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Irinotecan delivery by lipid-coated mesoporous silica nanoparticles shows improved efficacy and safety over liposomes for pancreatic cancer. ACS Nano 10, 2702\u20132715 (2016).","journal-title":"ACS Nano"},{"key":"61434_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17033-7","volume":"11","author":"JE Blume","year":"2020","unstructured":"Blume, J. E. et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat. Commun. 11, 3662 (2020).","journal-title":"Nat. Commun."},{"key":"61434_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33044-y","volume":"13","author":"D Baimanov","year":"2022","unstructured":"Baimanov, D. et al. In situ analysis of nanoparticle soft corona and dynamic evolution. Nat. Commun. 13, 5389 (2022).","journal-title":"Nat. Commun."},{"key":"61434_CR35","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41416-020-01066-2","volume":"123","author":"M Nonaka","year":"2020","unstructured":"Nonaka, M. et al. Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours. Br. J. Cancer 123, 1633\u20131643 (2020).","journal-title":"Br. J. Cancer"},{"key":"61434_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1469-7793.2001.0785e.x","volume":"532","author":"MH Wu","year":"2001","unstructured":"Wu, M. H., Ustinova, E. & Granger, H. J. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J. Physiol. 532, 785\u2013791 (2001).","journal-title":"J. Physiol."},{"key":"61434_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s12276-021-00558-2","volume":"53","author":"F Ciregia","year":"2021","unstructured":"Ciregia, F. et al. Modulation of \u03b1V\u03b26 integrin in osteoarthritis-related synovitis and the interaction with VTN(381-397 a.a.) competing for TGF-\u03b21 activation. Exp. Mol. Med. 53, 210\u2013222 (2021).","journal-title":"Exp. Mol. Med."},{"key":"61434_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0143-z","volume":"9","author":"R Du","year":"2018","unstructured":"Du, R. et al. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer. Cell Death Dis. 9, 126 (2018).","journal-title":"Cell Death Dis."},{"key":"61434_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1083\/jcb.201111077","volume":"197","author":"M Nagae","year":"2012","unstructured":"Nagae, M. et al. Crystal structure of \u03b15\u03b21 integrin ectodomain: atomic details of the fibronectin receptor. J. Cell Biol. 197, 131\u2013140 (2012).","journal-title":"J. Cell Biol."},{"key":"61434_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.00001.2003","volume":"83","author":"P Tuma","year":"2003","unstructured":"Tuma, P. & Hubbard, A. L. Transcytosis: crossing cellular barriers. Physiol. Rev. 83, 871\u2013932 (2003).","journal-title":"Physiol. Rev."},{"key":"61434_CR41","volume":"10","author":"M Romain","year":"2020","unstructured":"Romain, M., Thiroux, B., Tardy, M., Quesnel, B. & Thuru, X. Measurement of protein-protein interactions through microscale thermophoresis (MST). Bio Protoc. 10, e3574 (2020).","journal-title":"Bio Protoc."},{"key":"61434_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","volume":"21","author":"RJ Slack","year":"2022","unstructured":"Slack, R. J., Macdonald, S. J. F., Roper, J. A., Jenkins, R. G. & Hatley, R. J. D. Emerging therapeutic opportunities for integrin inhibitors. Nat. Rev. Drug Discov. 21, 60\u201378 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61434_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/acsnano.8b06164","volume":"13","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Improved efficacy and reduced toxicity using a custom-designed irinotecan-delivering silicasome for orthotopic colon cancer. ACS Nano 13, 38\u201353 (2019).","journal-title":"ACS Nano"},{"key":"61434_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jss.2015.04.030","volume":"199","author":"KP Terracina","year":"2015","unstructured":"Terracina, K. P. et al. Development of a metastatic murine colon cancer model. J. Surg. Res. 199, 106\u2013114 (2015).","journal-title":"J. Surg. Res."},{"key":"61434_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120117","volume":"593","author":"V Makwana","year":"2021","unstructured":"Makwana, V., Karanjia, J., Haselhorst, T., Anoopkumar-Dukie, S. & Rudrawar, S. Liposomal doxorubicin as targeted delivery platform: current trends in surface functionalization. Int. J. Pharm. 593, 120117 (2021).","journal-title":"Int. J. Pharm."},{"key":"61434_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrm1661","volume":"6","author":"V Gerke","year":"2005","unstructured":"Gerke, V., Creutz, C. E. & Moss, S. E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6, 449\u2013461 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61434_CR47","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61434-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:51:51Z","timestamp":1757253111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61434-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61434"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61434-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6531"}}